WHO ICTRP trial
Efficacy and safety of TAF vs TDF used in early and middle pregnancy with CHB
ChiCTR2500098753 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500098753 |
|---|---|
| Public title | Efficacy and safety of TAF vs TDF used in early and middle pregnancy with CHB |
| Scientific title | Safety and efficacy of TAF in pregnant women with chronic hepatitis B in the first and second trimesters: a multicenter prospective cohort study |
| Primary sponsor | The Third Affiliated Hospital of Guangzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Pregnancy with chronic viral hepatitis B |
| Interventions | TAF antiviral group:NA;TDF antiviral group:NA |
| Registration date | Mar 13, 2025 |
| Target size | TAF antiviral group:408;TDF antiviral group:408 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: